SkinCancer360

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy
Featured image for “Checkpoint Therapeutics Receives Approval for PD-L1 Therapy”

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy

December 16, 2024
The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
Featured image for “A Brief History of Mohs Surgery”

A Brief History of Mohs Surgery

September 16, 2024
The widely used technique for removing nonmelanoma skin cancers, Mohs micrographic surgery, began in a small lab in Wisconsin during…
[wpb_childpages]

Recent Posts

Featured image for “SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress  ”
Apr. 23, 2026

SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress  

Featured image for “Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    ”
Oct. 08, 2025

Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    

Featured image for “Preparing for Your First Oncology Visit: A Complete Guide for Skin Cancer Patients”
Sep. 29, 2025

Preparing for Your First Oncology Visit: A Complete Guide for Skin Cancer Patients

Featured image for “Skin Cancer in Aging Veterans: Unique Risks & Considerations”
Sep. 05, 2025

Skin Cancer in Aging Veterans: Unique Risks & Considerations

Featured image for “The Genetics of Skin Cancer: Insights from Dr. Kenneth Tsai”
Aug. 25, 2025

The Genetics of Skin Cancer: Insights from Dr. Kenneth Tsai

Post Categories